Chugai, US Foundation Medicine Team Up with NCC for Blood-Based Genomic Testing

February 17, 2020
Chugai Pharmaceutical and Roche’s US subsidiary Foundation Medicine said on February 13 that the companies have entered into a partnership agreement with the National Cancer Center (NCC) for a large cancer genomic screening project in Japan. Foundation Medicine owns its...read more